{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["Ruta chalepensis", "Rutaceae", "bioactivity", "biosynthesis", "chalepensin", "chalepin"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "33799365", "DateCompleted": {"Year": "2021", "Month": "05", "Day": "10"}, "DateRevised": {"Year": "2021", "Month": "05", "Day": "10"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "03", "Day": "14"}], "Language": ["eng"], "ELocationID": ["1609", "10.3390/molecules26061609"], "Journal": {"ISSN": "1420-3049", "JournalIssue": {"Volume": "26", "Issue": "6", "PubDate": {"Year": "2021", "Month": "Mar", "Day": "14"}}, "Title": "Molecules (Basel, Switzerland)", "ISOAbbreviation": "Molecules"}, "ArticleTitle": "Chalepin and Chalepensin: Occurrence, Biosynthesis and Therapeutic Potential.", "Abstract": {"AbstractText": ["Dihydrofuranocoumarin, chalepin (<b>1</b>) and furanocoumarin, chalepensin (<b>2</b>) are 3-prenylated bioactive coumarins, first isolated from the well-known medicinal plant <i>Ruta chalepensis</i> L. (Fam: Rutaceae) but also distributed in various species of the genera <i>Boenminghausenia</i>, <i>Clausena</i> and <i>Ruta</i>. The distribution of these compounds appears to be restricted to the plants of the family Rutaceae. To date, there have been a considerable number of bioactivity studies performed on coumarins <b>1</b> and <b>2</b>, which include their anticancer, antidiabetic, antifertility, antimicrobial, antiplatelet aggregation, antiprotozoal, antiviral and calcium antagonistic properties. This review article presents a critical appraisal of publications on bioactivity of these 3-prenylated coumarins in the light of their feasibility as novel therapeutic agents and investigate their natural distribution in the plant kingdom, as well as a plausible biosynthetic route."]}, "AuthorList": [{"Identifier": ["0000-0002-1157-2405"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Laboratory of Growth Regulators, Institute of Experimental Botany ASCR and Palack\u00fd University, \u0160lechtitel\u016f 27, 78371 Olomouc, Czech Republic."}], "LastName": "Nahar", "ForeName": "Lutfun", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Centre for Natural Products Discovery, School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, James Parsons Building, Byrom Street, Liverpool L3 3AF, UK."}], "LastName": "Al-Majmaie", "ForeName": "Shaymaa", "Initials": "S"}, {"Identifier": ["0000-0003-4664-914X"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Centre for Natural Products Discovery, School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, James Parsons Building, Byrom Street, Liverpool L3 3AF, UK."}], "LastName": "Al-Groshi", "ForeName": "Afaf", "Initials": "A"}, {"Identifier": ["0000-0001-9669-7364"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Cell and Molecular Biology Lab, Department of Zoology, Government College University, Faisalabad 38000, Pakistan."}], "LastName": "Rasul", "ForeName": "Azhar", "Initials": "A"}, {"Identifier": ["0000-0003-4038-0514"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Centre for Natural Products Discovery, School of Pharmacy and Biomolecular Sciences, Liverpool John Moores University, James Parsons Building, Byrom Street, Liverpool L3 3AF, UK."}], "LastName": "Sarker", "ForeName": "Satyajit D", "Initials": "SD"}], "GrantList": [{"GrantID": "No. CZ.02.1.01/0.0/0.0/16_019/0000868", "Agency": "the European Regional Development Fund", "Country": ""}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Molecules", "NlmUniqueID": "100964009", "ISSNLinking": "1420-3049"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Coumarins"}, {"RegistryNumber": "0", "NameOfSubstance": "Furocoumarins"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "13164-03-9", "NameOfSubstance": "3-(alpha,alpha-dimethylallyl)psoralen"}, {"RegistryNumber": "13164-04-0", "NameOfSubstance": "chalepin"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["chemistry"], "DescriptorName": "Clausena"}, {"QualifierName": ["chemistry"], "DescriptorName": "Coumarins"}, {"QualifierName": ["biosynthesis", "pharmacology"], "DescriptorName": "Furocoumarins"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["metabolism", "pharmacology"], "DescriptorName": "Plant Extracts"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["chemistry"], "DescriptorName": "Ruta"}, {"QualifierName": ["chemistry"], "DescriptorName": "Rutaceae"}], "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Joshi B.S., Gawad D.H. Isolation of some furanocoumarins from Clausena indica and identity of chalepensin with xylotenin. Phytochemistry. 1971;10:480\u2013481. doi: 10.1016/S0031-9422(00)94087-1.", "ArticleIdList": ["10.1016/S0031-9422(00)94087-1"]}, {"Citation": "Mohr N., Budzikiewicz H., El-Tawil B.A.H., El-Beih F.K.A. Further furoquinoline alkaloids from Ruta chalepensis. Phytochemistry. 1982;21:1838\u20131839. doi: 10.1016/S0031-9422(82)85091-7.", "ArticleIdList": ["10.1016/S0031-9422(82)85091-7"]}, {"Citation": "Richardson J.S.M., Sethi G., Lee G.S., Malek S.N.A. Chalepin: Isolated from Ruta angustifolia L. Pers induces mitochondrial mediated apoptosis in lung carcinoma cells. BMC Complementary Altern. Med. 2016;16:389. doi: 10.1186/s12906-016-1368-6.", "ArticleIdList": ["10.1186/s12906-016-1368-6", "PMC5059921", "27729078"]}, {"Citation": "Tamene D., Endale M. Antibacterial activity of coumarins and carbazole alkaloids from roots of Clausena anisata. Adv. Pharmacol. Sci. 2019;2019:5419854. doi: 10.1155/2019/5419854.", "ArticleIdList": ["10.1155/2019/5419854", "PMC6378073", "30863444"]}, {"Citation": "Quintanilla-Licea R., Mata-Cardenas B.D., Vargas-Villarreal J., Bazaldua-Rodriguez A.F., Angeles-Hernandez I.K., Garza-Gonzalez J.N., Hernandez-Garcia M.E. Antiprotozoal activity against Entamoeba histolytica of plants used in northeast Mexican traditional medicine. Bioactive compounds from Lippia graveolens and Ruta chalepensis. Molecules. 2014;19:21044\u201321065. doi: 10.3390/molecules191221044.", "ArticleIdList": ["10.3390/molecules191221044", "PMC6271573", "25517343"]}, {"Citation": "Yamahara J., Miki S., Murakami H., Matsuda H., Fujimura H. Screening test for calcium antagonists in natural products. The active principles of Boebminghausenia albiflora var. japonica. Yakuhaku Zasshi. 1987;107:823\u2013826. doi: 10.1248/yakushi1947.107.10_823.", "ArticleIdList": ["10.1248/yakushi1947.107.10_823", "3440926"]}, {"Citation": "Hu S., Guo J.-M., Zhang W.-H., Zhang M.-M., Liu Y.-P., Fu Y.-H. Chemical constituents from stems and leaves of Clausena emarginata. China J. Chin. Mater. Med. 2019;44:2096\u20132101.", "ArticleIdList": ["31355567"]}, {"Citation": "Adebajo A.C., Iwalewa E.O., Obuotor E.M., Ibikunle G.F., Omisore N.O., Adewunmi C.O., Obaparusi O.O., Klaes M., Adetogun G.E., Schmidt T.J., et al. Pharmacological properties of the extract and some isolated compounds of Clausena lansium sten bark: Anti-trichomonal, antidiabetic, anti-inflammatory, hepatoprotective and antioxidant effects. J. Ethnopharmacol. 2009;122:10\u201319. doi: 10.1016/j.jep.2008.11.015.", "ArticleIdList": ["10.1016/j.jep.2008.11.015", "19095054"]}, {"Citation": "Garcia-Beltran O., Areche C., Cassels B.K., Suarez L.E.C. Coumarins isolated from Esenbeckia alata (Rutaceae) Biochem. Syst. Ecol. 2014;52:39\u201340. doi: 10.1016/j.bse.2013.12.011.", "ArticleIdList": ["10.1016/j.bse.2013.12.011"]}, {"Citation": "Oliveira F.M., Santana A.E.G., Conserva L.M., Maia J.G.S., Guilhon G.M.P. Alkaloids and coumarins from Esenbeckia species. Phytochemistry. 1996;41:647\u2013649. doi: 10.1016/0031-9422(95)00564-1.", "ArticleIdList": ["10.1016/0031-9422(95)00564-1"]}, {"Citation": "Richardson J.S.M., Aminudin N., Malek A., Nurestri S. A Compound from Ruta angustifolia L. Pers exhibits cell cycle arrest at s phase, suppresses nuclear factor-kappa B (NF-kappa B) pathway, signal transducer and activation of transcription 3 (STAT3) phosphorylation and extrinsic apoptotic pathway in non-small cell lung cancer carcinoma (A549) Pharmacogn. Mag. 2017;13:S489\u2013S498.", "ArticleIdList": ["PMC5669087", "29142404"]}, {"Citation": "Fakai M.I., Malek S.N.A., Karsani S.A. Induction of apoptosis by chalepin through phosphatidylserine externalisations and DNA fragmentation in breast cancer cells (MCF7) Life Sci. 2019;220:186\u2013193. doi: 10.1016/j.lfs.2019.01.029.", "ArticleIdList": ["10.1016/j.lfs.2019.01.029", "30682342"]}, {"Citation": "Ulubelen A., Ertugrul L., Birman H., Yigit R., Erseven G., Olgac V. Antifertility effects of some coumarins isolated from Ruta chalepensis and R. chalepensis var. latifolia in rodents. Phytother. Res. 1994;8:233\u2013236. doi: 10.1002/ptr.2650080409.", "ArticleIdList": ["10.1002/ptr.2650080409"]}, {"Citation": "Elbeih F.K., Eltawil B.A.H., Baghlaf A.O. Constituents of local plants.12. Coumarin and chalepensin, a further constituent of Ruta chalepensis L. J. Chin. Chem. Soc. 1981;28:237\u2013238. doi: 10.1002/jccs.198100043.", "ArticleIdList": ["10.1002/jccs.198100043"]}, {"Citation": "Al-Majmaie S., Nahar L., Sharples G.P., Wadi K., Sarker S.D. Isolation and antimicrobial activity of rutin and its derivatives from Ruta chalepensis (Rutaceae) growing in Iraq. Rec. Nat. Prod. 2019;13:64\u201370. doi: 10.25135/rnp.74.18.03.250.", "ArticleIdList": ["10.25135/rnp.74.18.03.250"]}, {"Citation": "Orlita A., Sidwa-Gorycka M., Paszkiewicz M., Malinski E., Mumirska J., Siedlecka E.M., Lojkowska E., Stepnowski P. Application of chitin and chitosan as elicitors of coumarins and furoquinoline alkaloids in Ruta graveolens l. (Common rue) Biotechnol. Appl. Biochem. 2008;51:91\u201396. doi: 10.1042/BA20070200.", "ArticleIdList": ["10.1042/BA20070200", "18211259"]}, {"Citation": "Wu T.S., Shi L.S., Wang J.J., Iou S.C., Chang H.C., Chen Y.P., Kuo Y.H., Chang Y.L., Teng C.M. Cytotoxic and antiplatelet aggregation principles of Ruta graveolens. J. Chin. Chem. Soc. 2003;50:171\u2013178. doi: 10.1002/jccs.200300024.", "ArticleIdList": ["10.1002/jccs.200300024"]}, {"Citation": "Ulubelen A., Doganca S. Constituents of the aerial parts of Ruta montana. Fitoterapia. 1991;62:279."}, {"Citation": "Anaya A.L., Macias-Rubalcava M., Cruz-Ortega R., Garcia-Santana C., Sanchez-Monterrubio P.N., Hernandez-Bautista B.E., Mata R. Allelochemicals from Stauranthus perforatus, a Rutaceous tree of the Yucatan Peninsula, Mexico. Phytochemistry. 2004;66:487\u2013494. doi: 10.1016/j.phytochem.2004.12.028.", "ArticleIdList": ["10.1016/j.phytochem.2004.12.028", "15694456"]}, {"Citation": "Yang Q.-Y., Tian X.-Y., Fang W.-S. Bioactive coumarins from Boenninghausenia sessilicarpa. J. Asian Nat. Prod. Res. 2007;9:59\u201365. doi: 10.1080/10286020500382397.", "ArticleIdList": ["10.1080/10286020500382397", "17365191"]}, {"Citation": "Wei L., Xiang X.-G., Wang Y.-Z., Li Z.-Y. Phylogenetic relationships and evolution of the Androecia in Ruteae (Rutaceae) PLoS ONE. 2015;10:e0137190. doi: 10.1371/journal.pone.0137190.", "ArticleIdList": ["10.1371/journal.pone.0137190", "PMC4557828", "26332986"]}, {"Citation": "Heinke R., Franke K., Porzel A., Wessjohann L.A., Ali N.A.A., Schmidt J. Furanocoumarins from Dorstenia foetida. Phytochemistry. 2011;72:929\u2013934. doi: 10.1016/j.phytochem.2011.03.008.", "ArticleIdList": ["10.1016/j.phytochem.2011.03.008", "21492886"]}, {"Citation": "Sarker S.D., Nahar L. Progress in the chemistry of naturally occurring coumarins. Prog. Chem. Org. Nat. Prod. 2017;106:241\u2013304.", "ArticleIdList": ["28762091"]}, {"Citation": "Nahar L., Sarker S.D. Chemistry for Pharmacy Students: General, Organic and Natural Product Chemistry. 2nd ed. Wiley and Sons; Chichester, UK: 2019."}, {"Citation": "Sharma R.B., Raj K., Kapil R.S. Biosynthesis of chalepin in Ruta graveolens. Indian J. Chem. Sect. B\u2014Org. Chem. Incl. Med. Chem. 1998;37:247\u2013251."}, {"Citation": "Grundon M.F. Biosynthesis of aromatic hemiterpenes. Tetrahedron. 1978;34:143\u2013161. doi: 10.1016/S0040-4020(01)93598-7.", "ArticleIdList": ["10.1016/S0040-4020(01)93598-7"]}, {"Citation": "Gali L., Bedjou F., Velikov K.P., Ferrari G., Donsi F. High-pressure homogenization-assisted extraction of bioactive compounds from Ruta chalepensis. J. Food Meas. Charact. 2020;14:2800\u20132809. doi: 10.1007/s11694-020-00525-x.", "ArticleIdList": ["10.1007/s11694-020-00525-x"]}, {"Citation": "G\u00fcnaydin K., Savci S. Phytochemical studies on Ruta chalepensis (LAM) Lamarck. Nat. Prod. Res. 2005;19:203\u2013210. doi: 10.1080/14786410310001630546.", "ArticleIdList": ["10.1080/14786410310001630546", "15702632"]}, {"Citation": "Kong Y.C., Lau C.P., Wat K.H., Ng K.H., But P.P., Cheng K.F., Waterman P.G. Antifertility principles of Ruta graveolens. Planta Med. 1989;55:176\u2013178. doi: 10.1055/s-2006-961917.", "ArticleIdList": ["10.1055/s-2006-961917", "2748734"]}, {"Citation": "Orabi K.Y., El Sayed K.A. Biocatalytic studies of the furanocoumarins angelicin and chalepensin. Nat. Prod. Commun. 2007;2:565\u2013569. doi: 10.1177/1934578X0700200510.", "ArticleIdList": ["10.1177/1934578X0700200510"]}, {"Citation": "Gomez-Flores R., Gloria-Garza M.A., de la Garza-Ramos M.A., Quintanilla-Licea R., Tamez-Guerra P. Antimicrobial effect of chalepensin against Streptococcus mutans. J. Med. Plants Res. 2016;10:631\u2013634."}, {"Citation": "Al-Majmaie S., Nahar L., Rahman M.M., Nath S., Saha P., Talukdar A.D., Sharples G.P., Sarker S.D. Anti-MRSA constituents from Ruta chalepensis, and in silico studies on two of most active compounds, chalepensin and 6-hydroxy-rutin 3\u2032,7-dimethyl ether. Molecules. 2021 doi: 10.3390/molecules26041114. in press.", "ArticleIdList": ["10.3390/molecules26041114", "PMC7923287", "33669881"]}, {"Citation": "Quintanilla-Licea R., Mata-Cardenas B.D., Vargas-Villarreal J., Bazaldua-Rodriguez A.F., Verde-Star M.J. Antiprotozoal activity against Entamoeba histolytica of furocoumarins isolated from Ruta chalepensis. Planta Med. 2016;82:424. doi: 10.1055/s-0036-1596528.", "ArticleIdList": ["10.1055/s-0036-1596528", "0"]}, {"Citation": "Kundu S., Roy D. Computational study of glyceraldehyde-3-phosphate dehydrogenase of Entamoeba histolytica: Implications for structure-based drug design. J. Biomol. Struct. Dyn. 2007;25:25\u201333. doi: 10.1080/07391102.2007.10507152.", "ArticleIdList": ["10.1080/07391102.2007.10507152", "17676935"]}, {"Citation": "de Marchi A.A., Castilho M.S., Nascimento P.G.B., Archanjo F.C., Del Ponte G., Oliva G., Pupo M.T. New 3-piperonylcoumarins as inhibitors of glycosomal glyceraldehyde-3-phosphate dehydrogenase (gGAPDH) from Trypanosoma cruzi. Bioorg. Med. Chem. 2004;12:4823\u20134833. doi: 10.1016/j.bmc.2004.07.018.", "ArticleIdList": ["10.1016/j.bmc.2004.07.018", "15336261"]}, {"Citation": "Menzes I.R.A., Lopes J.C.D., Montanari C.A., Oliva G., Pavao F., Castilho M.S., Vieira P.A., Pupo M.T. 3D QSAR studies on binding affinities of coumarin natural products for glycosomal GAPDH of Trypanosoma cruzi. J. Comput. Aided Mol. Des. 2003;17:277\u2013290. doi: 10.1023/A:1026171723068.", "ArticleIdList": ["10.1023/A:1026171723068", "14635721"]}, {"Citation": "Pavao F., Castilho M.S., Pupo M.T., Dias R.L.A., Correa A.G., Fernandes J.B., da Silva M.F.G.F., Mafezoli J., Vieira P.C., Oliva G. Structure of Trypanosoma cruzi glycosomal glyceraldehyde-3-phosphate dehydrogenase complexed with chalepin, a natural inhibitor, at 1.95 angstrom resolution. FEBS Lett. 2002;520:13\u201317. doi: 10.1016/S0014-5793(02)02700-X.", "ArticleIdList": ["10.1016/S0014-5793(02)02700-X", "12044862"]}, {"Citation": "Vieira P.C., Mafezoli J., Pupo M.T., Fernandez J.B., da Silva M.F.G.F., de Albuquerque S., Oliva G., Pavao F. Strategies for the isolation and identification of trypanocidal compounds from the Rutales. Pure Appl. Chem. 2000;73:617\u2013622. doi: 10.1351/pac200173030617.", "ArticleIdList": ["10.1351/pac200173030617"]}, {"Citation": "Wahyuni T.S., Widyawaruyanti A., Lusida M., Fuad A., Soetjipto A., Fuchino H., Kawahara N., Hayashi Y., Aoki C., Hotta H. Inhibition of hepatitis C virus replication by chalepin and pseudane IX isolated from Ruta angustifolia leaves. Fitoterapia. 2014;99:276\u2013283. doi: 10.1016/j.fitote.2014.10.011.", "ArticleIdList": ["10.1016/j.fitote.2014.10.011", "25454460"]}, {"Citation": "Wahyuni T.S., Permanasari A.A., Widyawaruyanti A., Hafid A.F., Fuchino H., Kawahara N., Hotta H. Enhancement of anti-hepatitis C virus activity by the combination of chalepin from Ruta angustifolia and current antiviral drugs. Southeast. Asian J. Trop. Med. Public Health. 2020;51:18\u201325."}, {"Citation": "Lin Y.S., Wang Q., Gu Q., Zhang H.A., Jiang C., Hu J.Y., Wang Y., Yan Y., Xu J. Semisynthesis of (-)-rutamarin derivatives and their inhibitory activity against Esptein-Barr virus lytic replication. J. Nat. Prod. 2017;80:53\u201360. doi: 10.1021/acs.jnatprod.6b00415.", "ArticleIdList": ["10.1021/acs.jnatprod.6b00415", "28093914"]}, {"Citation": "Fakai M.I., Karsani S.A., Malek S.N.A. Chalepin and rutamarin isolated from Ruta angustifolia inhibit cell growth in selected cancer cell lines (MCF7, MDA-MB-231, HT29, and HCT116) J. Inf. Syst. Technol. Manag. 2017;2:8\u201317."}, {"Citation": "Rizvi S.H., Shoeb A., Kapil R.S., Popli S.P. Medicinal plants 7. Spasmolytic coumarins from Boenninghausenia Albiflora. Indian J. Pharm. Sci. 1979;41:205\u2013206."}, {"Citation": "Lo W.S., Lim Y.P., Chen C.C., Hsu C.C., Soucek P., Yun C.H., Xie W., Ueng Y.F. A dual function of the furanocoumarin chalepensin in inhibiting CYP2a and inducing CYP2b in mice: The protein stabilization and receptor-mediated activation. Arch. Toxicol. 2012;86:1927\u20131938. doi: 10.1007/s00204-012-0902-7.", "ArticleIdList": ["10.1007/s00204-012-0902-7", "22790670"]}, {"Citation": "Lo W.-S., Chang Y.-P., Chen C.-C., Chung Y.-T., Liu T.-Y., Murayama N., Yamazaki H., Soucek P., Chai G.Y., Chi C.W. Metabolism-enhanced inhibition of human and mouse cytochrome P4502A enzymes by chalepensin in vitro and in vivo. Drug Metab. Rev. 2011;43:44\u201345."}, {"Citation": "Ueng Y.-F., Chen C.-C., Chung Y.-T., Liu T.-Y., Chang Y.-P., Lo W.-S., Murayama N., Yamazaki H., Soucek P., Chau G.-Y. Mechanism-based inhibition of cytochrome P450 (CYP)2A6 by chalepensin in recombinant systems, in human liver microsomes and in mice in vivo. Br. J. Pharmacol. 2011;163:1250\u20131262. doi: 10.1111/j.1476-5381.2011.01341.x.", "ArticleIdList": ["10.1111/j.1476-5381.2011.01341.x", "PMC3144538", "21418183"]}, {"Citation": "Ueng Y.-F., Chen C.-C., Chung Y.-T., Liu T.-Y., Chang Y.-P., Lo W.-S. Corrigendum. Br. J. Pharmacol. 2012;165:2808."}, {"Citation": "Ueng Y.-F., Chen C.-C., Yamazaki H., Kiyotani K., Chang Y.P., Lo W.S., Li D.T., Tsai P.L. Mechanism-based inhibition of CYP1A1 and CYP3A4 by the furanocoumarin chalepensin. Drug Metab. Pharmacokinet. 2013;28:229\u2013238. doi: 10.2133/dmpk.DMPK-12-RG-113.", "ArticleIdList": ["10.2133/dmpk.DMPK-12-RG-113", "23257392"]}, {"Citation": "Ueng Y.-F., Chen C.-C., Huang Y.-L., Lee I.-J., Yun C.-H., Chen Y.-H., Huang C.-C. Effects of aqueous extracts of Ruta graveolens and its ingredients in cytochrome P450, uridine diphosphate (UDP)-glucuronosyltransferase, and reduced nicotinamide adenine dinucleotide (phosphate) (NAD(P)H)-quinone oxidoreductase in mice. J. Food Drug Anal. 2015;23:516\u2013528. doi: 10.1016/j.jfda.2015.03.005.", "ArticleIdList": ["10.1016/j.jfda.2015.03.005", "28911711"]}, {"Citation": "Uwaifo A.O. Analysis of structure activity relationship in the mutagenicity of aflatoxin B-1 and 4 other furocoumarins in Chinese hamster V-9 cells. Life Sci. Adv. 1984;3:62\u201370."}, {"Citation": "Emerole G., Thabrew M.I., Anosa V., Okorie D.A. Structure-activity-relationship in the toxicity of some naturally occurring coumarins-chalepin, imperatorin and oxypeucedanine. Toxicology. 1981;20:71\u201380. doi: 10.1016/0300-483X(81)90107-4.", "ArticleIdList": ["10.1016/0300-483X(81)90107-4", "7268793"]}, {"Citation": "El Sayed K., Al-Said M.S., El-Feraly F.S., Ross S.A. New quinoline alkaloids from Ruta chalepensis. J. Nat. Prod. 2000;63:995\u2013997. doi: 10.1021/np000012y.", "ArticleIdList": ["10.1021/np000012y", "10924184"]}, {"Citation": "World Health Organization (WHO) Hepatitis C.\n  2020.  [(accessed on 30 January 2021)]; Available online:  https://www.who.int/news-room/fact-sheets/detail/hepatitis-c."}, {"Citation": "Mishra S., Pandey A., Manvati S. Coumarin: An emerging antiviral agent. Heliyon. 2020;6:e03217. doi: 10.1016/j.heliyon.2020.e03217.", "ArticleIdList": ["10.1016/j.heliyon.2020.e03217", "PMC7002824", "32042967"]}, {"Citation": "Sarker S.D., Nahar L., Miron A., Guo M. In: Medicinal Natural Products\u2014A Disease-focused Approach. Sarker S.D., Nahar L., editors. Volume 55. Elsevier; London, UK: 2020. pp. 45\u201375."}, {"Citation": "Vicahi V., Kanyawim K. Sulforhodamine B colorimetric assay for cytotoxicity screening. Nat. Protoc. 2006;1:1112\u20131116. doi: 10.1038/nprot.2006.179.", "ArticleIdList": ["10.1038/nprot.2006.179", "17406391"]}, {"Citation": "Lipinski C.A., Lombardo F., Dominy B.W., Feeney P.J. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. 2001;46:3\u201326. doi: 10.1016/S0169-409X(00)00129-0.", "ArticleIdList": ["10.1016/S0169-409X(00)00129-0", "11259830"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "2", "Day": "24"}, {"Year": "2021", "Month": "3", "Day": "11"}, {"Year": "2021", "Month": "3", "Day": "12"}, {"Year": "2021", "Month": "4", "Day": "3", "Hour": "1", "Minute": "2"}, {"Year": "2021", "Month": "4", "Day": "4", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "5", "Day": "11", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "3", "Day": "14"}], "PublicationStatus": "epublish", "ArticleIdList": ["33799365", "PMC7999183", "10.3390/molecules26061609", "molecules26061609"]}}], "PubmedBookArticle": []}